ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,310.00
0.00%
Dow Jones
38,386.09
0.38%
Brent Oil
87.395
0.13%
Bitcoin
63,152.90
-1.07%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/30/20244:00AMGlobeNewswire Inc.Nokia and Vodafone complete successful Open RAN trial in Italy0HAF
04/30/20244:00AMBusiness WireU.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
04/30/20244:00AMGlobeNewswire Inc.One Za’abeel launches The Offices, Dual Licensed Office Space in One Za’abeel Tower
04/30/20244:00AMBusiness WireMerge Expands Footprint in Europe, Facilitating Product Integrations for GDPR-Compliant Companies
04/30/20244:00AMGlobeNewswire Inc.U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
04/30/20244:00AMGlobeNewswire Inc.U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)NASDAQ:ALVOAlvontech
04/30/20244:00AMBusiness WireU.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)NASDAQ:ALVOAlvontech
04/30/20244:00AMBusiness Wire Forrester annonce le programme complet du CX Summit EMEA 2024NASDAQ:FORRForrester Research Inc
04/30/20244:00AMGlobeNewswire Inc.Share Buyback Transaction Details April 25 – April 29, 2024TG:WOSBWolters Kluwers NV
04/30/20244:00AMGlobeNewswire Inc.Share Buyback Transaction Details April 25 – April 29, 2024EU:WKLWolters Kluwers NV
04/30/20244:00AMBusiness WireGecko Robotics and Al Masaood Energy Partner to Help ADNOC Gas Revolutionize Asset Operations and Maintenance with AI and Advanced Robotics
04/30/20244:00AMBusiness WireForrester Announces Full Conference Agenda For CX Summit EMEA 2024NASDAQ:FORRForrester Research Inc
04/30/20244:00AMGlobeNewswire Inc.One Za’abeel launches The Offices, Dual Licensed Office Space in One Za’abeel Tower
04/30/20244:00AMBusiness WireTabletop Tactics Selects Edgio to Deliver Premium Video Content GloballyNASDAQ:EGIOEdgio Inc
04/30/20244:00AMGlobeNewswire Inc.U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
04/30/20244:00AMGlobeNewswire Inc.Share Buyback Transaction Details April 25 – April 29, 2024XE:WOSBWolters Kluwers NV
04/30/20244:00AMBusiness WireThe Bliss Group Opens London Office to Support Clients in the UK
04/30/20243:59AMBusiness WireCommuniqué de mise à disposition du Document d’enregistrement universel 2023 de l’AFD
04/30/20243:56AMGlobeNewswire Inc.Form 8.5 (EPT/RI) - Accrol Group Holdings Plc
04/30/20243:55AMAlliance NewsAlliance NewsLONDON MARKET OPEN: HSBC and Prudential bookend FTSE 100
04/30/20243:51AMPR Newswire (US)An insider's guide to cultural exploration in Wuhan for Labor Day Holiday
04/30/20243:49AMGlobeNewswire Inc.Form 8.5 (EPT/RI) - Mattioli Woods Plc
04/30/20243:47AMPR Newswire (US)TDR Capital and I Squared Capital successful in bid for Applus Services S.A.
04/30/20243:41AMGlobeNewswire Inc.Form 8.5 (EPT/RI) - musicMagpie Plc
04/30/20243:41AMPR Newswire (US)TDR Capital and I Squared Capital successful in bid for Applus Services S.A.
04/30/20243:36AMAlliance NewsAlliance NewsTOP NEWS: Prudential's first quarter provides "sound base" for 2024LSE:PRUPrudential Plc
04/30/20243:36AMAlliance NewsAlliance NewsTOP NEWS: Prudential's first quarter provides "sound base" for 2024LSE:PRUPrudential Plc
04/30/20243:30AMPR Newswire (US)PREMIUM INC. Selects CLEVR to implement Mendix Digital Lifecycle Management to connect their ecosystem
04/30/20243:29AMBusiness WireT-Mobile Announces Proposed Public Offering of Euro-Denominated Senior NotesNASDAQ:TMUST Mobile US Inc
04/30/20243:27AMGlobeNewswire Inc.Qalbox, Islamic Streaming Service, Partners with NoorKids and Durioo+ to Enrich Islamic Learning for Children

Your Recent History

USOTC
RONN
Ronn Motor (PK)
USOTC
ACRL
Atacama Resources (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
ILST
International Star (PK)
NASDAQ
DJT
Trump Media and Technology
USOTC
NSAV
Net Savings Link (PK)
USOTC
AHRO
Authentic (CE)
NASDAQ
PLUG
Plug Power
USOTC
KEGS
1812 Brewing (PK)
USOTC
CNNA
Cann American (CE)
USOTC
TONR
Tonner One World (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
DKSC
Dakshidin (PK)
USOTC
CEOS
CeCors (PK)
NASDAQ
TSLA
Tesla
USOTC
GVSI
Good Vibrations Shoes (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved